Cochoco, Jacob .

HRN: 26-41-61  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/21/2024
CEFUROXIME 750MG (VIAL)
12/21/2024
12/28/2024
IV
630mg
Q8h
Dengue Fever With WS
Waiting Final Action 

Indication:  Empiric    Type of Infection:  BloodstreamMultiple Infections (tick All Sites)    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: